Cameco Corporation $CCJ Position Increased by Bowen Hanes & Co. Inc.

Bowen Hanes & Co. Inc. boosted its position in shares of Cameco Corporation (NYSE:CCJ) (TSE:CCO) by 9.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 574,475 shares of the basic materials company’s stock after purchasing an additional 51,000 shares during the period. Bowen Hanes & Co. Inc. owned 0.13% of Cameco worth $48,175,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Barings LLC acquired a new stake in shares of Cameco during the 3rd quarter valued at about $2,540,000. Hillsdale Investment Management Inc. lifted its stake in Cameco by 42.5% in the third quarter. Hillsdale Investment Management Inc. now owns 241,383 shares of the basic materials company’s stock valued at $20,253,000 after acquiring an additional 71,935 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its position in Cameco by 83.8% in the third quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 8,370 shares of the basic materials company’s stock worth $702,000 after acquiring an additional 3,815 shares in the last quarter. Bridgewater Advisors Inc. increased its stake in shares of Cameco by 5.5% during the 3rd quarter. Bridgewater Advisors Inc. now owns 3,414 shares of the basic materials company’s stock worth $308,000 after purchasing an additional 177 shares during the last quarter. Finally, King Luther Capital Management Corp raised its holdings in shares of Cameco by 7.2% during the 3rd quarter. King Luther Capital Management Corp now owns 1,065,310 shares of the basic materials company’s stock valued at $89,337,000 after purchasing an additional 71,283 shares in the last quarter. 70.21% of the stock is owned by institutional investors and hedge funds.

Cameco News Summary

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: GLJ Research reiterated a buy rating on Cameco, supporting upside sentiment from some sell‑side firms that expect continued strength in uranium demand. GLJ Research Reiterates Buy for Cameco (NYSE:CCJ)
• Positive Sentiment: MarketBeat highlighted a bullish, longer-term case that global adoption of nuclear power could keep demand for uranium—and Cameco’s revenues—elevated, a thematic driver that has helped CCJ’s recent run. Can Cameco Continue Its Run?
• Neutral Sentiment: Scotiabank trimmed its FY2027 EPS forecast for Cameco slightly (from $1.53 to $1.48) but left an Outperform rating in place—this is a modest earnings haircut rather than a full-scale outlook change, so the impact may be limited unless revisions accelerate. MarketBeat: Cameco / Scotiabank Note
• Negative Sentiment: Zacks Research downgraded Cameco from “strong-buy” to “hold,” which can pressure momentum players and reduce near-term buying conviction. Zacks.com
• Negative Sentiment: There was unusually large put option activity—roughly 28,210 puts (about a 942% increase vs. average)—indicating elevated hedging or speculative bearish positioning that can amplify intraday volatility and signal downside risk if sentiment shifts. Investors Buy High Volume of Cameco Put Options

Cameco Price Performance

Shares of NYSE:CCJ opened at $121.16 on Friday. The company has a market cap of $52.77 billion, a price-to-earnings ratio of 124.91 and a beta of 0.99. The business has a 50 day moving average price of $108.78 and a 200 day moving average price of $93.40. The company has a quick ratio of 1.85, a current ratio of 2.47 and a debt-to-equity ratio of 0.14. Cameco Corporation has a twelve month low of $35.00 and a twelve month high of $135.24.

Cameco (NYSE:CCJ) (TSE:CCO) last issued its quarterly earnings results on Friday, February 13th. The basic materials company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.07. The company had revenue of $874.57 million during the quarter, compared to analyst estimates of $782.13 million. Cameco had a return on equity of 9.35% and a net margin of 17.00%.The company’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the company earned $0.36 earnings per share. Research analysts predict that Cameco Corporation will post 1.27 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on CCJ shares. Raymond James Financial reiterated an “outperform” rating on shares of Cameco in a report on Wednesday, January 14th. UBS Group started coverage on Cameco in a research note on Monday, November 10th. They set a “neutral” rating and a $140.00 price target for the company. Wall Street Zen downgraded Cameco from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. National Bank Financial reaffirmed an “outperform” rating on shares of Cameco in a research report on Thursday, November 6th. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $131.00 price target on shares of Cameco in a report on Wednesday, February 4th. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Cameco currently has an average rating of “Moderate Buy” and an average price target of $143.03.

Cameco Company Profile

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.